unknown
Stage
1
Investors
About
CaLycia Bioscience is a Salt Lake City–based biotechnology company developing engineered macrophage cell therapies for central nervous system (CNS) tumors. Their approach uses locally administered, autologous macrophages designed to infiltrate neural tissue, phagocytose tumor cells, and present antigens to stimulate adaptive immunity against glioblastoma and brain metastases.
Explore CaLycia Bioscience's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.